Discussion of the “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Lokhnygina Yuliya  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 287-288

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Wassmer Gernot  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 289-291

Taylor & Francis Ltd

Access to resources Recommend Favorite

Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group

By Gallo Paul  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 275-283

Taylor & Francis Ltd

Access to resources Recommend Favorite

George Chi's Discussion of the “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development” By Christy Chuang-Stein, Vladimir Dragalin, Brenda Gaydos, Michael Krams, and José Pinheiro

By Chi George  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 285-286

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of the "White Paper of the PhRMA PISC Working Group on Adaptive Dose-Ranging Designs"

By Leonov Sergei  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1013-1014

Taylor & Francis Ltd

Access to resources Recommend Favorite